Skip to content

FERMEDICS

Active
Private limited companyfounded 20188 years activeGaston Crommenlaan 8, 9050 Gent, BelgiumKBO/BCE: BE 0698.608.846
Summary

FERMEDICS has been active since 2018 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €14,782 and a net result of -€60,586. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 23% of 266 sector peers (NACE 72, fiscal year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).

Overview

Activity
Research and development on biotechnology
NACE 72101
1 site
Size
€1.0mtotal assets 2025
Equity
€14,782
Loss
-€60,586
Turnover not published (abridged schema)
Financial health
83 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.3%
Structure
Largest shareholder
DEBOFIN · 12.5%
Accounts 11 days early0 of 4 deeds read
Why 83- Loss of €60,586, the second in a row (FY 2025)- Equity €14,782 (1.5% of total assets)+ Size: total assets €1.0m+ Sector Scientific research and development (NACE 72)Show the evidence

Checked score

Score 2025
83 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 21% of its sector peers (NACE 72, micro)
Financial strength · tick = 2024
Weak
Solvency 26-7
equity 1.5% of total assets
Liquidity 33-20
short-term debt 58.8% · cash 10.8%
Profitability 21+7
return on assets -6.0%
Bankruptcy probability, 12 months
0.3% Very low
0%0.5%1.5%4%10%≥ 25%

About 3 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.1% (936 companies)
Last 24 months 11-2024: 0.9% 12-2024: 0.4%▼ -0.5 percentage points vs 11-2024 01-2025: 0.4%● unchanged vs 12-2024 02-2025: 0.4%● unchanged vs 01-2025 03-2025: 0.4%● unchanged vs 02-2025 04-2025: 0.4%● unchanged vs 03-2025 05-2025: 0.4%● unchanged vs 04-2025 06-2025: 0.4%● unchanged vs 05-2025 07-2025: 0.4%● unchanged vs 06-2025 08-2025: 0.5%▲ +0.1 percentage points vs 07-2025 09-2025: 0.5%● unchanged vs 08-2025 10-2025: 0.6%▲ +0.1 percentage points vs 09-2025 11-2025: 0.4%▼ -0.2 percentage points vs 10-2025 12-2025: 0.5%▲ +0.1 percentage points vs 11-2025 01-2026: 0.9%▲ +0.4 percentage points vs 12-2025 02-2026: 1.1%▲ +0.2 percentage points vs 01-2026 03-2026: 1.2%▲ +0.1 percentage points vs 02-2026 04-2026: 1.8%▲ +0.6 percentage points vs 03-2026highest value 05-2026: 1.8%● unchanged vs 04-2026highest value 06-2026: 1.7%▼ -0.1 percentage points vs 05-2026 07-2026: 1.5%▼ -0.2 percentage points vs 06-2026 08-2026: 0.3%▼ -1.2 percentage points vs 07-2026lowest value 09-2026: 0.3%● unchanged vs 08-2026lowest value 10-2026: 0.3%● unchanged vs 09-2026lowest value
Credit up to €1,000 at 30 days acceptable
Liquidity tight (current ratio 1.33 against 2.15 in 2024; short-term debt: 58.8% and cash: 10.8% of total assets), and 98.5% of the assets are financed with debt.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 72, micro): better than 18% on solvency, 15% on liquidity and 29% on profitability.

The bankruptcy probability was computed on 07-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Seven signals.
−lowers risk+raises risk○neutral
lowers risk · Size: total assets €1.0m
The company's size counts in the probability; how much depends on the rest of its profile.
NBB · annual accounts
raises risk · Loss of €60,586, the second in a row (FY 2025)
NBB · annual accounts
raises risk · Equity €14,782 (1.5% of total assets)
NBB · annual accounts
lowers risk · Sector Scientific research and development (NACE 72)
KBO
raises risk · Persistent losses
Two consecutive loss-making years (2024 and 2025); equity is also lower. May indicate structural pressure on profitability.
NBB · annual accounts 2025
Net result per financial year
202122232425
2020 to 2025 · latest year -€60,586
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 23% of 266 sector peers (2025).
NBB · sector comparison
Position among 266 sector peers
Solvency
better than 23%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 20-07-2026, 11 days ahead of the deadline.
NBB · 6 filings
Deviation from the deadline
2025
11 days early
2024
on the day
2023
on the day
2022
4 days late
2021
44 days early
2020
321 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 6 accounts on average 45 days after the deadline; the sector median for financial year 2024 is 13 days before the deadline, and 32% of the sector filed late.

Checked, nothing found (1)
neutral · No strike-offs in the KBO publications
Checked from 2021 on.
KBO publications · our coverage
  1. Annual accounts filedfiscal year 2025 · abbreviated…
  2. Annual accounts filedfiscal year 2024 · micro…
  3. Annual accounts filedfiscal year 2023 · micro…

Key points

  • Caution: Equity fell in 2025from €75,368 to €14,782 ▼ 80.4% View
  • Caution: 2 loss-making years in a rowloss fiscal year 2025 -€60,586 View
  • Flemish supportawarded 2022 - 2025 €64,100 View

By topic

Financials

Fiscal year
2025
Total assets
€1.0m
Loss
-€60,586
Solvency
1.5%
Total assets▲ 3.1%
Net result
20202025
Go to Financials

Timeline

Events
10
Since
2021
  1. 31-03-2023Back to profit
  2. 04-11-2022Annual accounts filed
  3. 31-03-2022Weakest financial year
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Research and development on biotechnologyNACE 72101
Founded
19-06-2018
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.